Ossiform® and Finnadvance announce partnership
We are thrilled to announce that Finnadvance Ltd. has published a whitepaper in partnership with Ossiform®.
This whitepaper explores the various prospects of reconstructing microphysiological conditions of tissues and biological interfaces in a scalable fashion. This is done by employing microfluidics and combining the microfluid properties of AKITA® Plate with P3D Scaffolds from Ossiform®.
Under the partnership between Ossiform® and Finnadvance, the P3D Scaffolds is incorporated into the AKITA Plate. This combined platform will permit the test of bone repair studies in a high-throughput compatible manner while the flow of the Akita system increases the signal-to-noise ratio up to 5 times.
About Finnadvance Ltd. and AKITA
AKITA is the product line by Finnadvance Ltd., a Finnish biotechnology company that develops highly scalable organ-on-chip platforms. By enabling physiological model developments, drug development and research can be significantly accelerated, more cost and resource efficient, while producing more reliable results. We provide the highest throughput platforms with accurate biological modeling.
About Ossiform®
Ossiform® is dedicated to improving the lives of people with bone defects. We provide patient-matched, natural, and resorbable bone implants to reduce complications, improve functional and aesthetic outcomes and obtain faster recovery. We are continuously working to redefine bone replacements through progressive research and close collaboration with physicians and industry partners. Our patient-centric approach and commitment to innovation, quality, and progress steer our efforts to provide best-in-class implant solutions that facilitate the natural forming of new bone. Ossiform®’s unique bone printing technology is further used to provide customizable bone-mimetic constructs for enhancing bone and cancer research. In short: We Print Bone™.
Website: www.ossiform.com.